Article
The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer.
International journal of cancer - 15 Feb 2009
Weberpals Johanne, Garbuio Kyla, O'Brien Anna, Clark-Knowles Katherine, Doucette Steve, Antoniouk Olga, Goss Glenwood, Dimitroulakos Jim
Abstract excerpt
This study compares Breast Cancer 1 (BRCA1) and excision repair cross complementation group 1 (ERCC1) expression as predictive markers and evaluates the in vitro enhancement of platinum sensitivity using targeted agents in sporadic ovarian cancer (OC). A retrospective study was performed of advanced stage OC patients receiving platinum-based chemotherapy. BRCA1 and ERCC1 mRNA expression was determined from frozen...
Topics
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents
- BRCA1 Protein
- Carboplatin
- Cisplatin
- DNA Repair
- DNA-Binding Proteins
- Endonucleases
- Female
